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Organogenesis of the kidney glomerulus
Focus on the glomerular basement membrane
Jeffrey H. Miner
Renal Division; Department of Internal Medicine; Washington University School of Medicine; St. Louis, MO USA

T

he glomerular basement membrane
(GBM) is a crucial component of the
kidney’s filtration barrier that separates
the vasculature from the urinary space.
During glomerulogenesis, the GBM is
formed from fusion of two distinct basement membranes, one synthesized by
the glomerular epithelial cell (podocyte)
and the other by the glomerular endothelial cell. The main components of the
GBM are laminin-521 (α5β2γ1), collagen
α3α4α5(IV), nidogen and the heparan
sulfate proteoglycan, agrin. By studying
mice lacking specific GBM components,
we have shown that during glomerulogenesis, laminin is the only one that is
required for GBM integrity and in turn,
the GBM is required for completion of
glomerulogenesis and glomerular vascularization. In addition, our results from
laminin β2-null mice suggest that laminin-521, and thus the GBM, contribute
to the establishment and maintenance of
the glomerular filtration barrier to plasma
albumin. In contrast, mutations that affect
GBM collagen IV or agrin do not impair
glomerular development or cause immediate leakage of plasma proteins. However,
collagen IV mutation, which causes
Alport syndrome and ESRD in humans,
leads to gradual damage to the GBM
that eventually leads to albuminuria and
renal failure. These results highlight the
importance of the GBM for establishing
and maintaining a perfectly functioning,
highly selective glomerular filter.

the approximately 900 L of blood that
pass through them on a daily basis. Due
to resorption of water and solutes by the
tubular epithelial cells of the kidney, this
primary filtrate is concentrated to a urinary output of only 1–2 L. The glomerular filtration barrier, which lies between
the vasculature and the urinary space,
retards the passage of plasma proteins,
primarily of albumin and immunoglobulins, while ensuring the efficient flow
of water and small solutes that comprise
the primary filtrate. Since the realization
that the glomerular capillary wall consists
of two cells, podocyte and endothelium,
separated by an extracellular matrix called
the glomerular basement membrane
(GBM), there have been vigorous debates
about which of these three layers serves as
the major barrier to plasma proteins.1 In
this review, I will summarize our current
understanding of the cellular and extracellular components of the glomerular capillary wall and focus on the composition of
the GBM as it relates to glomerulogenesis,
permselectivity and kidney disease.
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Introduction
Human kidneys generate an enormous
primary filtrate of about 180 liters from
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The Glomerular
Filtration Barrier
The glomerular filtration barrier (Fig. 1) is
a three-layered structure that lies between
the vasculature and Bowman’s space.
Within the glomerulus, it is the only separation between the bloodstream and the
urine. The GBM is a specialized extracellular matrix situated between the podocytes and endothelial cells, which, during
glomerulogenesis, synthesize and secrete
components of the GBM. Furthermore,
both cell types are important for
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of filamentous plugs in the fenestrations.
These plugs are thought to be composed
of a form of glycocalyx (a sugary coat)
assembled by the glomerular endothelial
cells at their cell surfaces. These fenestral
plugs have been hypothesized to serve as
an impedance to the passage of plasma
proteins and therefore an important component of the glomerular filtration barrier
to albumin.8-10
Glomerular Basement Membrane
(GBM)
Figure 1. The ultrastructure of the glomerular filtration barrier. The capillary lumen is lined by
an endothelium with fenestrations (arrowheads). The endothelium is adjacent to the ribbon-like
glomerular basement membrane (GBM). Podocyte foot processes, which are bridged by slit diaphragms (arrows), abut the opposite aspect of the GBM and are surrounded by the primary filtrate
present in the urinary space.

maintaining the GBM’s structure and
function after glomerular maturation.2-4
Although the focus of this review is the
GBM, podocytes and endothelial cells
will also be discussed, as all three layers
are necessary for establishing and maintaining an intact filtration barrier.

and undergo a dramatic mesenchymeto-epithelium transition to form what is
referred to as the renal vesicle. Activation
of numerous important signaling pathways results in morphological changes to
the renal vesicle and segmentation of the
resulting “S-shaped” figure into the podocytes, the parietal epithelial cells that form
Bowman’s capsule,and the epithelial cells
that comprise the tubular segments of the
nephron.6

The GBM is, in some ways, a typical basement membrane: it has an electron-dense
lamina densa when viewed by transmission electron microscopy, and it is formed
by protein-protein interactions among the
same classes of macromolecules found in
all other basement membranes. However,
the GBM also has some atypical features.
First, it is unusually thick compared to
most other basement membranes; as
mentioned above, the GBM forms during glomerulogenesis by the fusion of
two distinct basement membranes, the
endothelial and the visceral epithelial
(or podocyte) basement membranes.3
Second, the GBM has an unusual composition compared to most other basement membranes, and this presumably
imparts its unique functional properties.
The GBM contains laminin, type IV collagen, nidogen and heparan sulfate proteoglycan (HSPG), components found in
all basement membranes, but for some of
these types of matrix proteins, the specific
isoforms present in the GBM are very different than those found elsewhere in basement membranes. Even the contiguous
Bowman’s capsule and tubular basement
membranes, for example, possess different complements of isoforms compared to
the GBM.
The GBM occupies a prime position
within the glomerular filtration barrier
(Fig. 1). In addition, it is very dense by
electron microscopy. Together with structural and functional data regarding the
GBM and other basement membranes,
published by many different labs over a
period of decades, we hypothesize that the
GBM functions by (1) providing adhesive
and signaling substrates to the adjacent
glomerular cells (podocytes, endothelial
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Podocytes

Podocytes, also called glomerular visceral
epithelial cells, are morphologically complex, nascent nephron epithelium-derived
cells that reside within the urinary space
(also called Bowman’s space) and are
therefore bathed in the primary urine.
Podocytes enwrap the outer aspect of the
glomerular capillaries by extending narrow foot processes that interdigitate with
those of adjacent podocytes. Juxtaposed
foot processes are directly linked to one
another by the glomerular slit diaphragms
(Fig. 1); these derive from gradual modification and apical-to-basal migration of
the tight junctions that originally joined
the previously columnar, immature
podocytes.5
Like the tubular epithelial cells of the
nephron, podocytes are descendants of
the metanephric mesenchyme, a population of intermediate mesoderm-derived
cells that are determined to form nephrons. At the beginning of development
of the definitive kidney, the ureteric bud
grows towards and into the metanephric
mesenchyme and induces it to condense
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Glomerular Endothelial Cells
Glomerular capillaries are lined by endothelial cells that are different than most,
because they bear many fenestrations
(Fig. 1). Fenestrations are seemingly patent “holes” in the endothelial cells that
allow the passage of fluid across the cell
layer. Ultrastructural analyses have shown
that some of these fenestrations have
wagon wheel-like diaphragms similar to
those found in peritubular capillaries and
in islet endothelial cells in the pancreas,
but many of the fenestrations in glomerular endothelial cells do not have diaphragms.7 This lack of diaphragms likely
allows more efficient flow of plasma across
this proximal layer of the glomerular filtration barrier.
Despite the presence of what usually appear by electron microscopy to be
unobstructed fenestrae in the glomerular
endothelium, special methods of fixation and staining indicate the presence
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cells and mesangial cells); (2) concentrating and presenting diffusible factors, such
as vascular endothelial growth factor; and
(3) contributing directly to the glomerular
filtration barrier to albumin. These functions, if correct, likely depend upon the
composition of the GBM, which will now
be discussed.
Laminin
Laminins are a family of large, evolutionarily related glycosylated proteins
that assemble with each other to form
at least 15 different αβγ heterotrimeric
macromolecules. These laminin trimers
are synthesized and secreted by diverse
cell types into the extracellular space.
Laminin trimers in the most recent laminin nomenclature scheme are named
based solely on their chain composition;
e.g., a trimer containing the laminin α5,
β2 and γ1 chains is called laminin-521, or
LM-521.11 Most laminin heterotrimers are
cross-shaped macromolecules (LM-521 is
shown in Fig. 2), with the one “long arm”
formed by association of the α, β and γ
chains via coiled-coil interactions and
disulfide bonding. The three free “short
arms” contain NH2-terminal globular
domains (called LN domains) that mediate laminin trimer-trimer interactions in
the extracellular space. These interactions
lead to laminin polymerization, which
initiates basement membrane formation.
The ~100 kDa laminin globular (LG)
domain at the distal end of the long arm
(found exclusively at the COOH termini
of α chains) mediates interactions with
integrin and nonintegrin receptors on
the surfaces of cells. A number of studies
have shown that laminin polymerization
in the extracellular space is required for
initiation of basement membrane formation. Moreover, laminin polymerization
via short arm-short arm interactions is
facilitated by LG domain interactions
with cellular receptors, likely due in part
to the increase in effective laminin concentration that results at cell surfaces.
Intracellular signaling events induced by
laminin binding are also involved in promoting laminin polymerization and basement membrane formation.12
LM-521 is the major laminin found
in the mature GBM, and it is secreted

Figure 2. The laminin-521 heterotrimer. This full-sized cruciform laminin is composed of the α5,
β2 and γ1 chains. Globular laminin amino-terminal (LN) domains interact with each other to facilitate laminin polymerization in the extracellular matrix. The α chain laminin globular (LG) domain
is recognized by receptors on cells, such as integrins, dystroglycan and the Lutheran blood group
glycoprotein.
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by both podocytes and endothelial cells.2
During the early stages of glomerulogenesis, when glomerular endothelial cells
are migrating towards the differentiating podocytes to begin to form the glomerular capillaries, and the GBM is first
recognizable as a distinct basement membrane, LM-111 and LM-511 are the major
laminin components.13 But as capillary
maturation begins, LM-521 is deposited
by both podocytes and endothelial cells,
and LM-111 and -511 are eventually eliminated.13,14 The molecular mechanisms that
drive the developmental transitions in
laminin expression and deposition have
yet to be discovered, but as discussed
below, these transitions are crucial to
ensure the establishment of a proper glomerular filtration barrier.
Type IV Collagen

Type IV collagen, like all collagens, is
secreted as a trimer (also called protomer)
composed of three α chains, the sequences
of which include collagenous regions that
consist of repeated Gly-X-Y amino acid
triplets. The presence of glycine at every
third residue is absolutely necessary to
allow the chains to assemble into a stable
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triple helix; this is because glycine is the
only amino acid with a side chain (a hydrogen) that is able to fit at the center of the
helix. But unlike the rigid fibril-forming
types of collagen that are associated with
bone and tendon, for example, the six distinct collagen IV α chains contain numerous interruptions of the Gly-X-Y repeats
that are scattered throughout the collagenous domain. These interruptions provide flexibility to the collagen IV trimers
and therefore to the collagen IV network,
which is formed by covalent and noncovalent interactions among trimers in the
extracellular matrix.15
Besides the central collagenous region
containing the Gly-X-Y interruptions, all
six collagen IV α chains bear a small noncollagenous NH2-terminal domain called
7S and a larger COOH-terminal noncollagenous domain called NC1. Both of
these domains are crucial for linking trimers to each other to promote collagen IV
network formation. Moreover, the NC1
domain plays an important role in directing the composition of collagen IV heterotrimers; information present within the
NC1 domain sequence ensures that only
three types of collagen IV trimers form:
(α1)2α2, α3α4α5 and (α5)2α6.16
77

motor neurons is crucial for development
and organization of the neuromuscular
junction.22 Although agrin is the major
GBM HSPG at maturity, during glomerular development there appears to be a
codistribution of agrin and perlecan, and
then perlecan disappears from the GBM
and becomes confined to the mesangial
matrix.23
The GBM’s Contribution
to Glomerulogenesis

Figure 3. Schematic diagram showing that GBM breakdown due to Lama5 mutation results in
failed glomerulogenesis. (A) A maturing wild-type (Lama5+/+) glomerulus with an intact podocyte
epithelium (green) and endothelium (yellow) flanking the GBM (red). Mesangial cells (blue) are
centrally located within the glomerulus, and parietal epithelial cells (not shown) sit on the Bowman’s capsule basement membrane (orange) and line Bowman’s space. (B) Failed glomerulogenesis in a Lama5-/- kidney. Discontinuities in the GBM (red) lead to stratification of the podocyte layer
(green) and disorganized endothelial and mesangial cells (yellow and blue, respectively).

The collagen IV network of the mature
GBM consists primarily of α3α4α5 heterotrimers. Grafting experiments in vivo
have shown that podocytes but not endothelial cells synthesize the α3α4α5 network,4 so it is likely the small amount of
collagen α1 and α2(IV) chains that are
present in the mature GBM derive mainly
from glomerular endothelial cells. Similar
to the situation for laminins discussed
above, there are developmental transitions
in collagen IV gene expression and collagen trimer deposition during glomerulogenesis. At the earliest stages, only the α1
and α2(IV) chains are detected, but as the
glomerular capillaries begin to mature,
there is a gradual increase in deposition of
the α3, α4 and α5 chains.14 This developmental transition in collagen IV network production has been shown to occur
during human, dog and mouse kidney
development.14,17,18

collagen networks. However, analysis
of single and double nidogen-1 and -2
knockout mice proved that basement
membranes can form in the absence of
either or both nidogen proteins, although
some basement membranes subjected to
high levels of stress during embryogenesis exhibit breaks and discontinuities in
the absence of both nidogens.20 As far as
the GBM is concerned, both nidogens-1
and -2 are present, but little is known
about their differential expression during
development.

Evidence that the GBM plays an important role in glomerulogenesis comes from
our studies of laminin α5 mutant and
transgenic mice. As alluded to above,
during glomerulogenesis there are developmental transitions in GBM components, including transitions from LM-111
to LM-511 and then to LM-521, which
is the mature isoform.13 The appearance of LM-511 in the nascent GBM is
accompanied by the abrupt removal/disappearance of LM-111 by an unknown
mechanism. When laminin α5 is knocked
out, LM-111 is still removed, and because
there is no polymerizing laminin trimer
present, the integrity of the GBM is compromised, and it breaks down.24 Without
a GBM, none of the three glomerular cell
types are able to maintain their positions
within the developing glomerulus, leading to a disorganized glomerulus (Fig. 3)
and failed glomerular vascularization.24
Subsequent studies of specific segments
of the laminin α5 COOH-terminal LG
domain reveal a previously unknown role
for laminin α5 in mediating adhesion of
mesangial cells to the GBM; this adhesion
is required for maintaining the capillary
looping that is a major anatomical characteristic of the glomerular tuft.25
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Nidogens
There are two nidogen proteins. Each is
a dumbbell-shaped basement membrane
component that binds tightly to the laminin γ1 chain short arm as well as to type
IV collagen.19 Therefore, nidogen was
thought initially to be crucial for basement
membrane formation as a potential link
between the separate laminin and type IV
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Heparan Sulfate
Proteoglycans (HSPGs)
HSPGs consist of a protein core with
covalently linked glycosaminoglycan side
chains that can dramatically increase the
molecular weight of the molecule. The
side chains are frequently modified by sulfation, which confers a significant anionic
charge to the proteoglycan and thus to the
basement membrane (or other extracellular matrix) in which the proteoglycan
is located. Although perlecan is probably
the most common HSPG found in most
basement membranes, the mature GBM
contains very little perlecan but, instead,
contains primarily agrin.21 Agrin plays an
important role in the neuromuscular system, where a special isoform secreted by
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The GBM’s Contribution
to Permselectivity
Since the discovery that nephrin (NPHS1),
a primary component of the glomerular
slit diaphragm, is mutated in congenital
nephrotic syndrome of the Finnish type,26
podocytes have been the major focus of
research aimed at defining the nature
of the glomerular filtration barrier and
understanding the etiology of glomerular disease. There is now known to be a
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large cohort of genes expressed in podocytes, the mutation of which in humans
and/or mice causes defects in glomerular
permselectivity, nephrotic range proteinuria and in some cases, focal segmental
glomerulosclerosis.27 This certainly lends
support to the concept that podocytes are
crucial for establishing and maintaining
the glomerular filtration barrier. However,
the GBM should not be ignored or forgotten.28 Of the nine proteins that are
known to be present in the mature GBM,
mutations that affect four of them cause
glomerular disease in humans (as well as
in mice), and mutation of a fifth causes
nephrotic syndrome in mice.29 These will
now be discussed.
The first GBM protein shown to be
affected in a human disease is collagen
α5(IV), which is encoded by COL4A5.30
Mutations in COL4A5 cause the X-linked
form of Alport syndrome, a hereditary
glomerulonephritis leading to kidney failure.31 As discussed above, the α5 chain is
a component of the α3α4α5(IV) trimer
that is present in the mature GBM. In
the absence of α5(IV), these trimers, and
thus the network they would normally
form within the GBM, are totally absent.
Likewise, homozygous or compound heterozygous mutations that affect the autosomal COL4A3 or COL4A4 genes also
prevent production of the α3α4α5(IV)
trimer and cause the more rare, autosomal
recessive form of Alport syndrome.
In the absence of the usual collagen
α3α4α5(IV) network that is present in
the GBM, there is substitution or compensation by the (α1)2α2(IV) network.32
Interestingly, in some Col4a3 -/- Alport
mice, especially those on the C57BL/6J
strain background, there is also compensation in the GBM by the (α5)2α6(IV)
network, which may slow progression of
the disease.33 Although this network functions adequately for several years in most
Alport syndrome patients, eventually there
is a characteristic splitting and thickening
of the GBM, visible by electron microscopy (Fig. 4), that sometimes imparts a
“basket weave” appearance. This pathology is associated first with hematuria and
later with proteinuria. Because proteinuria
is a relatively late feature of Alport syndrome, it seems that the identity of the
collagen IV network is not an important

Figure 4. The ultrastructure of Alport mouse GBM. In the absence of the collagen α3α45α5(IV)
network, the GBM becomes split and thickened, with moderately electron-lucent outpocketings
(asterisks). However, the endothelium and podocyte foot processes are mostly intact at this early
stage of the disease process.

determinant of glomerular permselectivity. It is important to note here that
dominant mutations in human COL4A1,
which encodes the collagen α1(IV) chain,
also cause several forms of kidney disease,
and there are a number of interesting
extrarenal manifestations.34,35
In contrast to the delayed onset proteinuria that develops in patients with
Alport syndrome, those with Pierson
syndrome, which is caused by truncating or severe missense mutations in the
laminin β2 gene LAMB2, exhibit congenital nephrotic syndrome and diffuse
mesangial sclerosis together with extrarenal manifestation such as small pupils
(microcoria) and neurological abnormalities.36,37 Lamb2-/- mice exhibit a phenotype that is consistent with that observed
in Pierson syndrome patients, including
nephrotic syndrome,38 severe neuromuscular abnormalities39 and retinal defects.40
Interestingly, unlike the GBM breakdown that occurs in mice lacking laminin α5,24 GBM integrity is maintained
in the absence of laminin β2. This is
likely because there is retention of laminin β1 in the mature Lamb2-/- GBM38 as
part of LM-511 and ectopically deposited
LM-111, LM-211 and perhaps LM-311.41
We concluded initially that laminin β1
compensates structurally for the missing laminin β2 but cannot compensate
functionally.38 However, currently we are
testing the alternative hypothesis that

the remaining laminin β1 in the GBM
is quantitatively insufficient compared to
the level of laminin β2 that is normally
present, and that artificially increasing
the level of β1 will increase the concentration of laminin trimers in the GBM and
thereby greatly improve the filtration barrier, perhaps by increasing the density of
the GBM.
Patients with what seem to be “less
severe” missense LAMB2 mutations also
have nephrotic syndrome, but it is accompanied by significantly milder extrarenal defects.42,43 These data suggest that
laminin β2 and the laminin-521 trimer
of which it is a component contribute to
the glomerular filter by imparting appropriate barrier properties to the GBM.
Indeed, our studies of Lamb2-/- mice
showed clearly that albuminuria is detectable before foot process effacement and
loss of slit diaphragms. Furthermore, foot
process and slit diaphragm formation normally occurrs in the absence of LM-521.
The straightforward interpretation is that
albumin leaks across the filtration barrier
because the GBM is defective, indicating
that the GBM must normally serve as an
important component of the filtration
barrier. Loss of foot processes is likely a
secondary response to proteinuria,41 but
this remains to be investigated.
We recently investigated the mechanism whereby a particular pathogenic
LAMB2 missense mutation (R246Q)
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found in a Turkish family42 causes congenital nephrotic syndrome. The mutation was
engineered into the rat laminin β2 cDNA
and expressed in the podocytes of transgenic mice in vivo via the mouse nephrin
promoter.44 Transgenes from three different founder lines were expressed at different relative levels, determined to be high,
medium and low based on mutant protein
accumulation in the GBM. These three
transgenes were bred individually onto the
Lamb2-/- background, so that all laminin
β2 in the GBM derived from the mutant
transgene. These mice developed proteinuria, the level of which was inversely proportional to the level of laminin β2 in the
GBM and in all cases much lower than
that observed in Lamb2-/- mice without the
transgene. Interestingly, the low expressor
had levels of laminin β2 mRNA in podocytes that were higher than that normally
observed for endogenous mouse laminin
β2, suggesting that the nephrin promoter
was more than adequate for driving the
production of mutant laminin β2 mRNA,
in agreement with our previous studies
in reference 41 and 45. Because studies
of the R246Q mutant in transfected 293
cells suggest that the mutation somehow
inhibits laminin secretion, we concluded
that this mutation causes misfolding and
degradation of most of the laminin β2
polypeptide, but that the increased transcription imparted by the nephrin promoter allows the podocytes to overcome
the secretion defect and secrete enough
LM-521 into the GBM to make a partly
functional albumin barrier.44
Concerning the other components
of the GBM, lack of either nidogen-1 or
nidogen-2 results in viable mice20 and no
significant defects in glomerular filtration.
Similarly, podocyte-specific knockout
of agrin, which leads to its absence from
the GBM, has no discernible effect on the
filtration barrier, although its loss causes
a dramatic reduction in the GBM’s concentration of negatively charged sites.23
Finally, although no mutations affecting human laminin α5 or laminin γ1
have been discovered, likely due to early
prenatal lethality that should occur due
to widespread expression of both chains
during embryogenesis, podocyte-specific mutation of Lama5 in mice results
in proteinuria that, in many cases,

progresses to nephrotic syndrome and renal
failure.29
Questions and Answers
Dr. Dwight Towler, Ira M. Lang Professor
of Medicine and Developmental Biology,
Washington University School of
Medicine: I am curious about the potential for acquired dysfunctions in the laminin β chains. On that particular Arg246
of laminin β2, is it susceptible to modification by advanced glycation end products, for example? Do you know whether
or not one or more N-carboxymethyl arginine derivatives, advanced glycosylation
end products described in collagen in the
setting of diabetes, could also modify and
nullify the function of that β chain?
Dr. Jeffrey Miner: I don’t think anyone has looked at specific residues of laminins in the setting of hyperglycemia.
Dr. Towler: The structure-function
implications from the family with Pierson
syndrome phenotypes and your elegant
data point to that possibility. It is clearly
an important region of laminin β2 with
respect to glomerular basement membrane
function and proteinuria; I was wondering
whether or not some of the acquired albuminuria states and GBM deficiencies also
relate to biochemical modifications of that
same β2 arginine residue.
Dr. Miner: No, not that I know of.
Dr. Towler: I know this presentation
was “focused on the filter,” but I was curious about your hypomorphic mutation of
the α5 chain C terminus. Did you happen to note any structural defects that
occurred in the peritubular basement
membranes, where laminin-511 might be
important?
Dr. Miner: We did not, we focused on
the filter. That was the only place where
we found any obvious abnormalities. The
tubular basement membranes also have
other laminins. It is not pure LM-511.
Dr. Towler: So do you think that
the mesangial cell interaction with the
COOH terminus of laminin α5 is a fairly
specific interaction in the glomerular basement membrane?
Dr. Miner: Yes
Dr. Feng Chen, Assistant Professor
of Medicine and Cell Biology and
Physiology, Washington University

School of Medicine: I have two questions. First, GBM is made by endothelial
cells and podocytes, and I am wondering if anyone has looked carefully for any
qualitative or quantitative differences
between the contributions from these
two cell types. Second, in the laminin β2
knockouts, there is some β1 retention to
partially compensate for the problem. Do
you know if normally the β1 is from the
podocyte or from the endothelial cells?
Dr. Miner: Dale Abrahamson has
done a lot of work to address those issues,
at least the first one. He has shown that
the laminin is made by both, as he can
detect LM-521 within the endoplasmic
reticulum in both endothelial cells and
in podocytes.2 My personal opinion is
that podocytes make more, and that is
based on our finding that we can rescue
the laminin β2 knockout by only rescuing the podocytes and not affecting the
endothelial cells, which don’t express
from the nephrin promoter that we used.45
Regarding collagen, it is a different story.
Dr. Abrahamson showed that only podocytes make the collagen α3/4/5 network,4
and that makes perfect sense because one
can always detect a low level of the α1/2
network on the subendothelial aspect of
the basement membrane. So if one thinks
about rescuing Alport syndrome, either
by gene therapy or bone marrow stem
cells, there would need to be an effect on
the podocyte side. Your second question
had to do with residual laminin β1 and
where that comes from. That is something
we don’t know and is something a student in my laboratory is working on. My
guess is that it is coming from both cells.
Sometimes we can detect a little bit of β1
even in a normal GBM, but I think the
levels of transcription are very low, because
these proteins are so long lived in the basement membrane; turnover is very slow, so
there never needs to be a lot of mRNA to
make a basement membrane. I think it
would be difficult for us to discover by in
situ hybridization, for example, which cell
is making β1. However, it is something we
are interested in figuring out.
Dr. Raphael Kopan, Professor of
Developmental Biology and of Medicine,
Washington University School of
Medicine: Have you looked to see if
you have phenotypes in animals that are

©201
1L
andesBi
os
c
i
enc
e.
Donotdi
s
t
r
i
but
e.

80

Organogenesis

Volume 7 Issue 2

heterozygous for the β1 chain, the β2
chain or trans-heterozygous for β1 and
β2? Your hypothesis predicts that it is
a quantitative rather than a qualitative
deficiency.
Dr. Miner: In every laminin mutant
that I know of there has never been a
defect shown in a heterozygote. Even
though it is quantitatively less transcription, the proteins are so long lived that
it doesn’t seem to take much mRNA to
make a normal basement membrane protein complement.
Dr. Kopan: What if you reduce the β1
on the β2 knockout background?
Dr. Miner: We haven’t done that. We
have β1 knockout animals; we should do
that experiment.
Dr. Helen Liapis, Professor of
Pathology and Immunology, Washington
University School of Medicine: You mentioned podocyte foot process effacement
as being caused by a variety of conditions, and your last diagram also points
out that defects in a lot of molecules may
lead to the same result. However, there are
nephrotic syndromes that are not associated with foot process effacement. Can
you try to explain that?
Dr. Miner: Well I know of endothelial cell injury in preeclampsia, and
that has been pretty well worked out by
Karumanchi and others.46,47 Our model,
I think, is also proteinuria without foot
process effacement. What are the other
instances?
Dr. Liapis: Well, my experience is
in humans. For instance, you can have
patients with crescentic glomerulonephritis and lots of protein loss, but they do not
have foot process effacement. We just had
a pediatric case the other day, and I was
scratching my head. Why does this kid
have proteinuria, if the podocytes look
normal and the foot processes are intact?
Is it possible that you can have acquired
laminin dysfunction?
Dr. Miner: I doubt it. It is possible
that something is directly impacting the
structure of the GBM, but I can’t imagine why that might happen other than
what Dr. Towler brought up. Thinking
about the intact nephron hypothesis, it

is possible that the biopsy did not get the
right glomeruli, and there might be leaking glomeruli with foot process effacement in other parts of the kidney.
Dr. Keith Hruska, Professor of
Pediatrics, Medicine and Cell Biology
and Physiology, Washington University
School of Medicine: For your Col4a3
model of Alport syndrome, you have
reported the switch to the collagen
α5/5/6(IV) network associated with
improved renal function.33 You mentioned
the potential for rescuing the laminin β2
knockout with a small molecule stimulator
of β1 expression. Has anybody been able
to use this approach to activate a switch to
induce podocytes to express ectopic α6 in
the GBM?
Dr. Miner: You mean in mice? No. In
theory, it should work in humans as well,
but no one has ever seen that same ectopic α5/5/6 collagen IV network in human
Alport patients. It seems to be a mousespecific phenomenon and has only been
shown to occur on the C57BL/6J background. The senior author of that paper
thinks that there is actually a SNP, or a
difference in the promoter of α5/6, that
allows high levels of α6 to be made. And
of course, most human Alport patients
have α5 mutations, so even if you could
activate α6 expression in podocytes, it
would not help without the α5. So that
approach couldn’t work for most patients.
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